Fingolimod improves the outcome of experimental Graves’ Disease and Associated orbitopathy by modulating the autoimmune response to the thyroid-stimulating hormone receptor - Plohn, S; Hose, M; Schluter, A (Thyroid : Official Journal of the American Thyroid Association, 2019)
et al.